Global Coronary Stents Market Outlook, Size, Status, and Forecast to 2024
Global Coronary Stents Market is projected to reach USD 6.4 billion by 2024, from USD 5.3 billion in 2017, at a CAGR of 2.4% during the forecast period from 2017 to 2024.-According to Data Bridge Market Research new Market report.
The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2017 and the forecast period is 2017 to 2024.
According to Data Bridge Market Research new Market report “Global Coronary Stents Market”
· By Type (Dual Therapy Stent, Bioresorbable Vascular Scaffold, Drug Eluting Stent (DES) (Paclitaxel, Limus-Based Drugs), Bio-Engineered Stent, Bare Metal Stent),
· By Absorption Rate (Slow-Absorption DES, Fast-Absorption (DES)),
· By Material (Stainless Steel, Cobalt Alloy Metal, Gold, Tantalum, Nitinol, Polymers), Rate (Slow-Absorption Stents, Fast-Absorption Stents),
· By Application (Coronary Artery Disease, Peripheral Artery Disease),
· By End-User (Hospitals, Cardiac Centers, Others),
· By Geography (North America, Europe, Asia-Pacific, Middle East And Africa, South America, Rest Of The World)
Free Sample Report Copy of Global Coronary Stents Market @ https://databridgemarketresearch.com/request-a-sample/?dbmr=coronary-stents-market
· The usage of coronary stent devices are increasing in today’s market due to the increase in number of heart diseases and other problems related to the cardiovascular system and also owing to its benefits such as reducing mortality, morbidity among the heart attack patients, improving the flow of blood immediately after heart attack, highly recommended for the heart patients having one or two blocked arteries.
· The coronary stent devices market will grow in the future because of the unhealthy diet, physical inactivity, unhealthy lifestyle.
· The combination of stent with angioplasty is a life saviour when it is performed after a heart attack.
· There are other benefits to the usage of coronary stent devices such as it can improve further damage to the heart, helps in improving the symptoms related to the heart diseases, shortness of breath and chest pain.
· There are two engines driving the rapid development of coronary stent devices.
1. The first is the elimination of coronary bypass surgery and it takes less recovery time as compared to the bypass surgery which takes nearly 6 weeks or longer to recover, early diagnosis and treatment of vascular disease.
2. The second engine is the extensive research carried out both by academic institutions and by manufacturers of coronary stent market.
According to British Heart Foundation Cardiovascular Disease Statistics, in 2014 approximately 26% of male and 18% of female premature (under-75s) mortality was attributed to CVD.In total there were almost 42,000 premature deaths from CVD in the UK. According to the WHO, an estimated 17.5 million people died from CVDs in 2012, representing 31% of all global deaths. Of these deaths, an estimated 7.4 million were due to coronary heart disease and 6.7 million were due to stroke. Over three-quarters of CVD deaths take place in low- and middle-income countries. Out of the 16 million deaths under the age of 70 due to no communicable diseases, 82% are in low and middle-income countries and 37% are caused by CVDs.
Whereas the main restraint for the coronary stent market is the strict government policies, unconscionable prices that the patients are paying for the stents which lead them into indebtness and in some cases leaves them without this life-saving treatment, price control on the cardiac stents by the local authority will lead to the halt of introduction of new advanced product in the region, just limited to one or two blocked arteries, for more complex cases of coronary heart disease, bypass surgery is a better choice.
Market Segmentation:
Global Coronary Stents Market is segmented on the basis of product type, usability, end-user, distribution channel and geography.
On the basis of the type, the market is segmented into dual therapy stent, bioresorbable vascular scaffold (BVS), drug-eluting stent (DES), bio-engineered stent, and bare metal stent. The drug eluting stent market is segmented into biodegradable and non-biodegradable. Also, based on drug, the market is segmented into paclitaxel and limus-based drugs.
Based on application, the market is segmented into coronary artery disease and peripheral artery disease.
On the basis of end-user, the market is segmented into hospitals and cardiac centers.
Based on geography the market is segmented into 5 geographical regions such as
1. North America,
2. Europe,
3. Asia-Pacific,
4. South America,
5. Middle East and Africa and,
6. Rest of the World.
The report of this market covers data points for 24 major countries which are
U.S. Canada,
Mexico,
Germany,
France,
U.K.,
Belgium,
Switzerland,
Belgium,
Turkey,
Japan,
China,
Singapore,
Brazil,
India,
Russia, and
South Africa.
The report includes company share data for different geographies including Global, North America, Europe and APAC.
Competitive Landscape: Major Players
Some of the other players in this market include
Abbott Vascular,
SciTech,
Boston Scientific Corporation,
Minvasys,
Medinol Ltd,
iVascular SLU,
Elixir Medical Corporation,
Inspire MD,
Stentys SA,
Hexacath,
Medtronic,
Andramed GmbH,
Cordis Corporation,
Orbusneich,
Eurocor GmbH,
Comed B.V.,
Endocor GmbH,
MicroPort Scientific Corporation,
Amaranth Medical, Inc.,
Terumo Corporation,
Degania Silicone Ltd.,
Meril Life Sciences Pvt. Ltd.,
InSitu Technologies Inc.,
Alvimedica,
Biotronik SE & Co. KG,
Elixir Medical Corporation,
AMG International GmbH,
Arthesys,
Lepu Medical,
Translumina GmbH,
Accura,
Svelte Medical,
B. Braun Melsungen AG and,
Eucatech AG among others.
Detailed Report Explain By Industry Experts @ https://databridgemarketresearch.com/news/product-launch/coronary-stents-market/
About Us-
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact Us-
Data Bridge Market Research
US: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
Website: https://databridgemarketresearch.com
The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2017 and the forecast period is 2017 to 2024.
According to Data Bridge Market Research new Market report “Global Coronary Stents Market”
· By Type (Dual Therapy Stent, Bioresorbable Vascular Scaffold, Drug Eluting Stent (DES) (Paclitaxel, Limus-Based Drugs), Bio-Engineered Stent, Bare Metal Stent),
· By Absorption Rate (Slow-Absorption DES, Fast-Absorption (DES)),
· By Material (Stainless Steel, Cobalt Alloy Metal, Gold, Tantalum, Nitinol, Polymers), Rate (Slow-Absorption Stents, Fast-Absorption Stents),
· By Application (Coronary Artery Disease, Peripheral Artery Disease),
· By End-User (Hospitals, Cardiac Centers, Others),
· By Geography (North America, Europe, Asia-Pacific, Middle East And Africa, South America, Rest Of The World)
Free Sample Report Copy of Global Coronary Stents Market @ https://databridgemarketresearch.com/request-a-sample/?dbmr=coronary-stents-market
· The usage of coronary stent devices are increasing in today’s market due to the increase in number of heart diseases and other problems related to the cardiovascular system and also owing to its benefits such as reducing mortality, morbidity among the heart attack patients, improving the flow of blood immediately after heart attack, highly recommended for the heart patients having one or two blocked arteries.
· The coronary stent devices market will grow in the future because of the unhealthy diet, physical inactivity, unhealthy lifestyle.
· The combination of stent with angioplasty is a life saviour when it is performed after a heart attack.
· There are other benefits to the usage of coronary stent devices such as it can improve further damage to the heart, helps in improving the symptoms related to the heart diseases, shortness of breath and chest pain.
· There are two engines driving the rapid development of coronary stent devices.
1. The first is the elimination of coronary bypass surgery and it takes less recovery time as compared to the bypass surgery which takes nearly 6 weeks or longer to recover, early diagnosis and treatment of vascular disease.
2. The second engine is the extensive research carried out both by academic institutions and by manufacturers of coronary stent market.
According to British Heart Foundation Cardiovascular Disease Statistics, in 2014 approximately 26% of male and 18% of female premature (under-75s) mortality was attributed to CVD.In total there were almost 42,000 premature deaths from CVD in the UK. According to the WHO, an estimated 17.5 million people died from CVDs in 2012, representing 31% of all global deaths. Of these deaths, an estimated 7.4 million were due to coronary heart disease and 6.7 million were due to stroke. Over three-quarters of CVD deaths take place in low- and middle-income countries. Out of the 16 million deaths under the age of 70 due to no communicable diseases, 82% are in low and middle-income countries and 37% are caused by CVDs.
Whereas the main restraint for the coronary stent market is the strict government policies, unconscionable prices that the patients are paying for the stents which lead them into indebtness and in some cases leaves them without this life-saving treatment, price control on the cardiac stents by the local authority will lead to the halt of introduction of new advanced product in the region, just limited to one or two blocked arteries, for more complex cases of coronary heart disease, bypass surgery is a better choice.
Market Segmentation:
Global Coronary Stents Market is segmented on the basis of product type, usability, end-user, distribution channel and geography.
On the basis of the type, the market is segmented into dual therapy stent, bioresorbable vascular scaffold (BVS), drug-eluting stent (DES), bio-engineered stent, and bare metal stent. The drug eluting stent market is segmented into biodegradable and non-biodegradable. Also, based on drug, the market is segmented into paclitaxel and limus-based drugs.
Based on application, the market is segmented into coronary artery disease and peripheral artery disease.
On the basis of end-user, the market is segmented into hospitals and cardiac centers.
Based on geography the market is segmented into 5 geographical regions such as
1. North America,
2. Europe,
3. Asia-Pacific,
4. South America,
5. Middle East and Africa and,
6. Rest of the World.
The report of this market covers data points for 24 major countries which are
U.S. Canada,
Mexico,
Germany,
France,
U.K.,
Belgium,
Switzerland,
Belgium,
Turkey,
Japan,
China,
Singapore,
Brazil,
India,
Russia, and
South Africa.
The report includes company share data for different geographies including Global, North America, Europe and APAC.
Competitive Landscape: Major Players
Some of the other players in this market include
Abbott Vascular,
SciTech,
Boston Scientific Corporation,
Minvasys,
Medinol Ltd,
iVascular SLU,
Elixir Medical Corporation,
Inspire MD,
Stentys SA,
Hexacath,
Medtronic,
Andramed GmbH,
Cordis Corporation,
Orbusneich,
Eurocor GmbH,
Comed B.V.,
Endocor GmbH,
MicroPort Scientific Corporation,
Amaranth Medical, Inc.,
Terumo Corporation,
Degania Silicone Ltd.,
Meril Life Sciences Pvt. Ltd.,
InSitu Technologies Inc.,
Alvimedica,
Biotronik SE & Co. KG,
Elixir Medical Corporation,
AMG International GmbH,
Arthesys,
Lepu Medical,
Translumina GmbH,
Accura,
Svelte Medical,
B. Braun Melsungen AG and,
Eucatech AG among others.
Detailed Report Explain By Industry Experts @ https://databridgemarketresearch.com/news/product-launch/coronary-stents-market/
About Us-
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact Us-
Data Bridge Market Research
US: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
Website: https://databridgemarketresearch.com